159 related articles for article (PubMed ID: 8115785)
1. Staging and survival of patients with renal cell carcinoma.
Guinan P; Frank W; Saffrin R; Rubenstein M
Semin Surg Oncol; 1994; 10(1):47-50. PubMed ID: 8115785
[TBL] [Abstract][Full Text] [Related]
2. Update on pathologic staging of renal cell carcinoma.
Gettman MT; Blute ML
Urology; 2002 Aug; 60(2):209-17. PubMed ID: 12137811
[No Abstract] [Full Text] [Related]
3. Renal cell carcinoma: comparison of the TNM and Robson stage groupings.
Guinan P; Saffrin R; Stuhldreher D; Frank W; Rubenstein M
J Surg Oncol; 1995 Jul; 59(3):186-9. PubMed ID: 7609526
[TBL] [Abstract][Full Text] [Related]
4. Independent validation of the 2010 American Joint Committee on Cancer TNM classification for renal cell carcinoma: results from a large, single institution cohort.
Kim SP; Alt AL; Weight CJ; Costello BA; Cheville JC; Lohse C; Allmer C; Leibovich BC
J Urol; 2011 Jun; 185(6):2035-9. PubMed ID: 21496854
[TBL] [Abstract][Full Text] [Related]
5. Is there a need to further subclassify pT2 renal cell cancers as implemented by the revised 7th TNM version?
Waalkes S; Becker F; Schrader AJ; Janssen M; Wegener G; Merseburger AS; Schrader M; Hofmann R; Stöckle M; Kuczyk MA
Eur Urol; 2011 Feb; 59(2):258-63. PubMed ID: 21030143
[TBL] [Abstract][Full Text] [Related]
6. Impact of tumor size on the clinical outcomes of patients with Robson State I renal cell carcinoma.
Kinouchi T; Saiki S; Meguro N; Maeda O; Kuroda M; Usami M; Kotake T
Cancer; 1999 Feb; 85(3):689-95. PubMed ID: 10091742
[TBL] [Abstract][Full Text] [Related]
7. Modified cancer TNM classification for localized renal cell carcinoma based on the prognostic analysis of 3748 cases from a single center.
Zhang J; Li X; Lin J; Liu Z; Tian Y; Wang Q
Can J Physiol Pharmacol; 2022 Jan; 100(1):5-11. PubMed ID: 34779659
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of the 1997 TNM classification of renal cell carcinoma.
Javidan J; Stricker HJ; Tamboli P; Amin MB; Peabody JO; Deshpande A; Menon M; Amin MB
J Urol; 1999 Oct; 162(4):1277-81. PubMed ID: 10492179
[TBL] [Abstract][Full Text] [Related]
9. [Survival analysis for localized renal cell carcinoma. Prognostic value of 1997 TNM classification].
García Torrelles M; Sánchez Sanchís M; Beltrán Armada JR; Bautista Rentero D; Vidal Moreno J; Sanjuán de Laorden C
Actas Urol Esp; 2006; 30(7):655-60. PubMed ID: 17058609
[TBL] [Abstract][Full Text] [Related]
10. A proposal for reclassification of the Fuhrman grading system in patients with clear cell renal cell carcinoma.
Sun M; Lughezzani G; Jeldres C; Isbarn H; Shariat SF; Arjane P; Widmer H; Pharand D; Latour M; Perrotte P; Patard JJ; Karakiewicz PI
Eur Urol; 2009 Nov; 56(5):775-81. PubMed ID: 19573980
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in renal cell cancer.
Park WH; Eisen T
BJU Int; 2007 May; 99(5 Pt B):1277-81. PubMed ID: 17441924
[No Abstract] [Full Text] [Related]
12. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria.
Tsui KH; Shvarts O; Smith RB; Figlin RA; deKernion JB; Belldegrun A
J Urol; 2000 Apr; 163(4):1090-5; quiz 1295. PubMed ID: 10737472
[TBL] [Abstract][Full Text] [Related]
13. Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases.
Delahunt B; Eble JN; McCredie MR; Bethwaite PB; Stewart JH; Bilous AM
Hum Pathol; 2001 Jun; 32(6):590-5. PubMed ID: 11431713
[TBL] [Abstract][Full Text] [Related]
14. The use of simplified versions of the Fuhrman nuclear grading system in clinical practice requires the agreement of a multidisciplinary panel of experts.
Ficarra V; Novara G; Martignoni G
Eur Urol; 2009 Nov; 56(5):782-4; discussion 784-5. PubMed ID: 19660853
[No Abstract] [Full Text] [Related]
15. Prognostic parameters in renal cell carcinoma--a new approach.
Störkel S; Thoenes W; Jacobi GH; Lippold R
Eur Urol; 1989; 16(6):416-22. PubMed ID: 2591426
[TBL] [Abstract][Full Text] [Related]
16. Pathologic staging of renal cell carcinoma: significance of tumor classification with the 1997 TNM staging system.
Gettman MT; Blute ML; Spotts B; Bryant SC; Zincke H
Cancer; 2001 Jan; 91(2):354-61. PubMed ID: 11180082
[TBL] [Abstract][Full Text] [Related]
17. Predictive ability of the 2002 and 2010 versions of the Tumour-Node-Metastasis classification system regarding metastasis-free, cancer-specific and overall survival in a European renal cell carcinoma single-centre series.
Pichler M; Hutterer GC; Chromecki TF; Jesche J; Kampel-Kettner K; Groselj-Strele A; Pummer K; Zigeuner R
BJU Int; 2013 Apr; 111(4 Pt B):E191-5. PubMed ID: 23107473
[TBL] [Abstract][Full Text] [Related]
18. Reevaluation of TNM staging of renal cortical tumors: recurrence and survival for T1N0M0 and T3aN0M0 tumors are equivalent.
Gilbert SM; Murphy AM; Katz AE; Goluboff ET; Sawczuk IS; Olsson CA; Benson MC; McKiernan JM
Urology; 2006 Aug; 68(2):287-91. PubMed ID: 16904438
[TBL] [Abstract][Full Text] [Related]
19. Proposal of an improved prognostic classification for pT3 renal cell carcinoma.
Terrone C; Gontero P; Volpe A; Porpiglia F; Bollito E; Zattoni F; Frea B; Tizzani A; Fontana D; Scarpa RM; Rossetti SR
J Urol; 2008 Jul; 180(1):72-8. PubMed ID: 18485380
[TBL] [Abstract][Full Text] [Related]
20. Validation of the ucla integrated staging system for patients with renal cell carcinoma.
Zisman A; Pantuck AJ; Figlin RA; Belldegrun AS
J Clin Oncol; 2001 Sep; 19(17):3792-3. PubMed ID: 11533107
[No Abstract] [Full Text] [Related]
[Next] [New Search]
